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ABSTRACT 
 
Basic fibroblast growth factor (bFGF) and growth and differentiation factor (GDF)-5 
stimulate the healing of medial collateral ligament (MCL) injury. However, the effect of 
isolated and combined use of bFGF/GDF-5 remains still unclear. We investigated cellular 
proliferation and migration responding to bFGF/GDF-5 using rabbit MCL fibroblasts. Rabbit 
MCL injury was treated by bFGF and/or GDF-5 with peptide hydrogels. Gene expression and 
deposition of collagens in healing tissues were evaluated. bFGF/GDF-5 treatment additively 
enhanced cell proliferation and migration. bFGF/GDF-5 hydrogels stimulated Col1a1 
expression without increasing Col3a1 expression. Combined use of bFGF/GDF-5 stimulated 
type I collagen deposition and the reorganization of fiber alignment, and induced better 
morphology of fibroblasts in healing MCLs. Our study indicates that combined use of 
bFGF/GDF-5 might enhance MCL healing by increasing proliferation and migration of MCL 
fibroblasts, and by regulating collagen synthesis and connective fiber alignment. 
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Introduction 
 
 Medial collateral ligament (MCL) injury frequently occurs in sports and trauma. 
Severe MCL injury results in the loss of joint function, which can lead to the poor 
performance in sports activities and the early development of osteoarthritis [1]. Experimental 
and clinical studies have revealed that MCL injury can heal spontaneously by conservative 
treatments. [1-3] However, connective fiber structure, biochemical composition, and 
biomechanical property of healed MCL are quite different from normal ligament [1]. 
 Several growth factors have been used in the application of tissue engineering to 
stimulate the proliferation and differentiation of mesenchymal cells [4-6]. Basic fibroblast 
growth factor (bFGF), epidermal growth factor (EGF), growth and differentiation factor 
(GDF), insulin-like growth factor, platelet-derived growth factor (PDGF), and transforming 
growth factor (TGF)-β have been reported to enhance the cellular responses of MCL cells 
[1,7,8]. The proliferation of ligament cells is stimulated by bFGF, EGF, and PDGF [9]. On 
the other hand, the syntheses of extracellular matrix (ECM) such as type I and III collagen are 
increased by TGF-β1 and GDF-5 treatments [7,10,11]. The TGF-β superfamily is a 
multifunctional growth factor, that include TGF-βs, GDFs, and bone morphogenetic proteins, 
for many cellular processes such as proliferation and differentiation [12,13]. We have 
previously demonstrated that bFGF acts as the major stimulator in cellular proliferation and 
migration of MCL fibroblasts [14]. The migration of MCL cells is also activated by GDF-5 
treatment in vitro. In addition, bFGF and GDF-5 individually increase the expression of α1(I) 
collagen gene (Col1a1), a major ECM component of ligament, in MCL cells [14]. The 
purpose of this study is to compare the availability of isolated and combined use of bFGF and 
GDF-5 for the healing and remodeling of injured MCL. 
 The paracrine communication among cells, growth factors, mechanical stresses, and 
bridging scaffolds is important for tissue regeneration and repairing process. The ideal 
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scaffold for ligament tissue engineering should be biodegradable, exhibit sufficient 
mechanical strength, and promote the formation of ligamentous tissue. Several authors have 
reported about potential ligament scaffolds using collagen, silk, biodegradable polymers, and 
composite materials [15-19]. As a major component of ligament, collagen scaffolds are 
temporally highlighted. However, their mechanical properties diminish rapidly with time 
even after cross-linking treatment. Furthermore, the profound immunogenic reactions also 
make a limitation in the clinical application of collagen scaffolds [8]. Silk has been studied as 
a candidate for ligament scaffold because of its biocompatibility, slow degradability, and 
remarkable mechanical capability [15,18]. On the other hand, the polymeric scaffolds using 
poly-glycolic acids and poly-lactic acids show excellent mechanical strength. However, their 
hydrophobicities prevent cellular adhesion, proliferation, and subsequent maturing steps [17]. 
In the present study, we used peptide hydrogels, that potentiate providing a delivery of 
growth factors at injured tissue [20], as a self-assembling biodegradable scaffold to promote 
the healing of MCL injury. 
 
Materials and methods 
 
Cells and cell culture: The Institutional Review Board approval was obtained before 
beginning all animal studies. Ligament fibroblasts were isolated from MCL of 10-week-old 
Japanese white rabbits (n = 4) (Shimizu Laboratory Supplies) with collagenase 
(Sigma-Aldrich) treatments as described [21]. Cells between passage 3 and 6 were used for 
experiments. Four different MCL fibroblasts were prepared and used for the following assays. 
 
Cell proliferation assay: Cell proliferation assays were performed as described previously 
[22]. To investigate the effect of bFGF and/or GDF-5, MCL cells were seeded as 1 x 104 
cells/well onto 96-well plates. A serum-free DMEM containing 0.1% BSA (Invitrogen) was 
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used as a control. Recombinant human bFGF (kindly provided by Kaken Pharmaceutical Co.) 
and recombinant human GDF-5 (BioVision) were used. These growth factors were added into 
serum-free DMEM at indicated concentrations (n = 5). Cells were incubated for 48 h prior to 
addition of WST-1 (Roche). The optical density (OD) was measured by using a Model 550 
microplate reader (Bio-Rad). The data obtained by subtraction of readings at 630 nm from 
those at 450 nm were used for evaluation. The mean value derived from 5 wells was 
evaluated. The assays were run in triplicate for each sample. 
 
Cell migration assay: Cell migration assays were performed in a modified Boyden chamber 
(48-well chemotaxis chamber AP48, Neuro Probe) as described previously [23]. 
Collagen-coated polycarbonate membrane (8 μm pore, Neuro Probe) was placed over the 
bottom chamber filled with a medium containing growth factors (bFGF, GDF-5, and 
bFGF/GDF-5) at indicated concentrations (n = 4). MCL cells (1 x 104 cells) were seeded in 
the upper chamber of each well. The assembled chamber was incubated for 8 h to allow cells 
for migration through the membrane. Non-migrating cells on the upper surface of the 
membrane were removed by scraping and the membrane was stained with Diff-Quik 
(Sysmex). The total number of cells with nuclei that migrated per well was counted as 
described [23]. The mean value derived from 4 wells was evaluated, and the assays were 
performed in triplicate for each sample. 
 
MCL injury model and growth factor treatment: Thirty female Japanese white rabbits with a 
body weight of 2.0-2.5 kg were used for this study. All experiments were performed under the 
approval of the Institutional Review Board. Following anesthesia, 3 cm skin incision was 
made in the medial side of the left knee, and the left MCL (width, approximately 4 mm) was 
exposed. A Penrose drain was placed underneath the MCL. Then, a full thickness partial 
excision of MCL was created by 3 mm diameter biopsy punch [24,25]. These excisions were 
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performed at proximal and distal one-third of MCL for RNA and histological analyses. The 
right MCL was used as a negative control. No treatment was applied in a group of partial 
excision control (n = 3). The defect was filled with 20 μl of bioabsorbable peptide hydrogels 
(PuraMatrix, BD) as a group of scaffold alone (n = 3). This 16 amino acid peptide 
(RADARADARADARADA) self-assembles into a nanofiber network. MCL treatments were 
performed using hydrogels contained 10 μg of each growth factor (bFGF, GDF-5, and 
bFGF/GDF-5; n = 3). After surgery, the animal was housed in a cage without knee 
immobilization until the time of evaluation. 
 
Histological analysis: Animals were sacrificed at 2 and 4 weeks after surgery. MCL samples 
were fixed by 10% formalin solution and embedded in paraffin blocks. Coronal sections of 
partially excised MCL lesions (6 μm thicknesses) were assessed by hematoxylin-eosin (HE) 
and Masson trichrome staining as described [12,23]. The organization of fibrous connective 
tissue at excised lesion was evaluated using fiber alignment score [26]. The appearance of 
cell shape was also assessed using morphology of fibroblasts score [26]. Histological finding 
was assessed by 5 independent investigators. 
 
Quantitative real-time PCR analysis: MCL samples at 2 and 4 weeks after surgery were harvested for 
RT-PCR analyses. Total RNA was isolated using ISOGEN reagent (Nippon Gene). RNA samples were 
reverse-transcribed with ReverTra Ace (Toyobo) to cDNAs. PCR amplification was performed in the 
presence of 10 pmol of each specific primer. The primer sets for rabbit Col1a1, Col3a1, 
glyceraldehyde-3-phosphate dehydrogenase (G3pdh) were used [14,27]. The cycle number was 
selected in the linear part of the amplification curve. Quantitative real-time PCR analyses were 
performed using Mx3000P instrument (Stratagene) and Brilliant II Fast SYBR Green QPCR Master 
Mix (Stratagene) as described [28]. Amplification of G3pdh was used for normalization. The final 
expression value was calculated in dividing each expression level of partial excision control. These 
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experiments were assessed in triplicate. 
 
Immunohistochemical analysis: MCL sections were also assessed by immunohistochemical 
analyses using anti-type I (Merck) and anti-type III (Monosan) collagen antibodies as described [21]. 
To quantify signal density, images were analyzed by Image J 1.31 as described [29]. The mean value 
derived from 5 different images was evaluated. 
 
Statistical analysis: Data were expressed as means SD. Differences among groups were 
compared by using the Mann-Whitney U-test. Statistical significance was established at 
p < 0.05. 
 
Results 
 
bFGF/GDF-5 treatment increases the cellular proliferation and migration of MCL fibroblasts 
The proliferation of bFGF- and bFGF/GDF-5-treated cells were increased up to 1.7- 
and 2.1-fold levels of control, respectively (Fig. 1A, 100 ng/ml). GDF-5 single treatment did 
not influence MCL cell proliferation (Fig. 1A, GDF-5). Combined use of bFGF/GDF-5 
induced similar increase of MCL cellular proliferation in comparison with bFGF alone (Fig. 
1A). MCL cell migration responding to bFGF and GDF-5 was increased to 2- and 2.5-fold 
levels of control, respectively (Fig. 1B, 100 ng/ml). In addition, bFGF and GDF-5 
cooperatively stimulated the migration of MCL cells (Fig. 1B, bFGF/GDF-5). These results 
prompted us to investigate the effect of bFGF/GDF-5 combined treatment in a ligament 
injury model. 
 
bFGF/GDF-5 hydrogels stimulate the healing of MCL injury 
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In rabbit MCL injury model, the combined treatment using bFGF/GDF-5 and 
hydrogels stimulated the healing of injured tissues. Remodeling of fiber alignment was 
improved in bFGF/GDF-5-hydrogel group (n = 3) at 4 weeks (Fig. 2, A and B). Fiber 
alignment score was higher in bFGF/GDF-5 hydrogels than in the other groups (Fig. 2D). 
Cellular morphology of bFGF/GDF-5-hydrogel group showed a fibroblast-like shape in 
repaired tissues (Fig. 2, A and B, 4 weeks). The evaluation score for the morphology of 
fibroblasts was higher in bFGF/GDF-5 hydrogels than in the other groups (Fig. 2F). 
 
Combined therapy using bFGF/GDF-5 hydrogels stimulates Col1a1 expression and type I 
collagen synthesis without increasing type III collagen deposition during ligament healing 
Combined treatment of bFGF/GDF-5 hydrogels increased Col1a1 expression in 
healing tissue at 2 weeks after MCL injury (Fig. 3A). However, GDF-5 hydrogels did not 
enhance the Col1a1 expression (Fig. 3, A and B). High amount of type I collagen synthesis 
was observed in bFGF/GDF-5-hydrogel group at 4 weeks after surgery (Fig. 4, A and D, 
bFGF/GDF-5). The alignment of type I collagen fibers was well-organized in 
bFGF/GDF-5-hydrogel group (Fig. 4A, 4 weeks). On the other hand, Col3a1 expression was 
stimulated by bFGF hydrogels at 2 weeks (Fig. 3C). bFGF hydrogels induced type III 
collagen deposition at 4 weeks (Fig. 4, B and F). GDF-5 hydrogels prevented the increase of 
Col3a1 expression in healing tissues (Fig. 3C). The deposition of type III collagen was poorly 
detected in GDF-5- and bFGF/GDF-5-hydrogel groups (Fig. 4, B, E, and F).  
 
Discussion 
 
 Growth factors and scaffolds that activate cellular proliferation and migration of 
ligament fibroblasts could potentially induce sufficient ECM synthesis and early ligament 
healing. bFGF-impregnated pellet using hydroxyethyl methacrylate stimulates initial 
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remodeling process with a decreased number of cells and better orientation of the collagen 
fibers in a canine anterior cruciate ligament (ACL) injury model [30]. A poly-L-lactic acid 
braid scaffold combined with bFGF and a gelatin hydrogel results in enhanced mechanical 
strength and collagen production of regenerated ACL tissue in a rabbit model [3]. The 
potential of synergistic effect of growth factors has also been investigated. A combination of 
TGF-β1 and PDGF does not enhance the structural property of healing MCL compared to the 
use of PDGF alone [31]. TGF-β2/PDGF treatment has no significant effect compared to 
TGF-β2 single treatment [32]. On the other hand, combined local application of TGF-β1 and 
EGF improves the structural property of tendon graft in an ACL reconstruction model [33]. 
Although TGF-β1 and GDF-5 synergistically stimulate the proliferation of bone 
marrow-derived stem cells on a braided poly(lactic-co-glycolic acid) scaffold, synergistic 
increase of collagen synthesis is not observed by the combination of TGF-β1/GDF-5 [34]. In 
the present study, we demonstrated that the combined use of bFGF and GDF-5 enhanced the 
well-organized deposition of type I collagen in injured MCL in vivo (Figs. 2-4). These 
findings suggest that the combined treatment using bFGF, GDF-5, and hydrogels may be a 
strong candidate to induce the optimum healing after ligament injury. This study includes 
several limitations such as MCL injury model, in vivo sample number, and lack of 
biomechanical analysis. To investigate ligament healing using animal models, reproducible 
injury must be created. Complete rupture model of MCL may represent sever MCL injury. 
However, scar formation at injured MCL is unstable and experimental assessment of 
repairing tissue is difficult. Although our partial excision model might not represent clinical 
MCL injury, ligament defect was prepared under certain conditions. Further investigations 
including biomechanical analysis will be required to understand the synergistic effect of 
bFGF and GDF-5 in ligament healing. 
Type I collagen is the predominant genetic type of collagen found in normal 
ligaments in a ratio of 3:1 with type III collagen [35]. In the process of ligament healing, the 
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deposition of type III collagen typically precedes that of type I collagen, and then type III 
collagen is replaced by the stiffer ECM molecule, type I collagen [36,37]. The early 
production of type III collagen might be important in establishing the initial wound structure 
and in providing a basic lattice for subsequent healing events [38]. However, type I collagen 
synthesis does not start after type III collagen deposition, but begins shortly after ligament 
injury [39]. It is probable that type III collagen might be predominantly synthesized in 
immature repairing tissues during ligament healing. To reduce undesirable ECM molecules in 
repairing tissue might potentiate inducing successful ligament healing. Antisense gene 
therapy against Decorin increases the diameters of collagen fibers and the tensile strength of 
healing ligament in a rabbit MCL injury model [40]. Suppression of Col3a1 expression using 
antisense oligonucleotides might be useful approach in the treatment of ligament injuries [19]. 
In this study, both the gene expression and protein deposition of type I collagen were 
increased by the combined treatment of bFGF and GDF-5 in the healing tissue after MCL 
injury (Figs. 3 and 4). On the other hand, the expression and deposition of type III collagen 
were stimulated in bFGF-hydrogel group, but not in bFGF/GDF-5-hydrogel group (Figs. 3C 
and 4). GDF-5 deficiency strongly increases Col3a1 expression in the infarct zone of heart 
after myocardial infarction using GDF-5 knockout mice [41]. The brachypodism mice that 
carry a functional null mutation of GDF-5 gene exhibit the hypoplasia of condyles and 
intra-articular ligaments in the knee joint, and result in anterior dislocation of the knee [42]. 
In addition, GDF-5 treatment reduces the expression of type III procollagen [11]. These 
findings suggest that GDF-5 might have a key role in the healing and development of 
ligaments by regulating the synthesis of type III collagen. 
In conclusion, our present study indicates that the combined use of bFGF, GDF-5, 
and hydrogels might enhance the healing of MCL injury by increasing the proliferation and 
migration of ligament fibroblasts, and by regulating the collagen synthesis and connective 
fiber alignment. 
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Figure legends 
 
Fig. 1. bFGF/GDF-5-combined treatment increases MCL cellular proliferation and 
migration. 
(A) MCL cell proliferation was increased up to 1.7- and 2.1-fold levels of control with bFGF 
and bFGF/GDF-5 treatments, respectively (100 ng/ml). Significant difference was observed 
between bFGF/GDF-5-treated cells and untreated cells. GDF-5 single treatment did not 
stimulate MCL cell proliferation in this assay. Open, light-gray, dark-gray, and filled bars 
indicate the index of OD (450-630 nm) at growth factor concentrations of 0, 1, 10, and 100 
ng/ml, respectively. Each datum is the mean of five different wells. * p < 0.05. 
(B) bFGF and GDF-5 enhanced MCL cell migration to 2- and 2.5-fold levels of control, 
respectively (100 ng/ml). Combined treatment of bFGF/GDF-5 increased the migration of 
MCL cells to a 4-fold level of control (100 ng/ml). Open, light-gray, dark-gray, and filled bars 
indicate the number of migrated cells in the presence of growth factors at concentrations of 0, 
1, 10, and 100 ng/ml, respectively. Each datum is the mean of four different wells. * p < 0.05. 
 
Fig. 2. bFGF/GDF-5 hydrogels promote the healing of rabbit MCL injury. 
(A, HE stain; B, Masson trichrome stain) Partial excision group showed irregular pattern of 
fiber alignment in healing tissues even at 4 weeks after surgery. Disorganized fibrous 
connective tissue was observed in hydrogel control group even at 4 weeks (A and B). On the 
other hand, bFGF and bFGF/GDF-5 hydrogels stimulated the reorganization of fiber 
alignment at 4 weeks. Bars, 25 μm. 
(C-F) The remodeling of injured MCL was stimulated by bFGF/GDF-5 hydrogels. 
Irregularity of fiber alignment was observed in partial excision group. Hydrogel control 
group also showed disorganized fiber alignment after MCL injury (C and D). The treatment 
with bFGF hydrogels increased fiber alignment score of damaged MCL (C and D). Further 
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improvement of fiber alignment was observed by the combined treatment of bFGF/GDF-5 
hydrogels at 4 weeks (D). The morphology of fibroblasts score was increased in 
bFGF/GDF-5-hydrogel group at 2 and 4 weeks after surgery (E and F). Open, dotted, 
diagonal-hatched, gray, and hatched gray bars indicate the score in the groups of no treatment, 
hydrogels alone, bFGF, GDF-5, and bFGF/GDF-5 hydrogels after partial excision of MCL, 
respectively. * p < 0.05. 
 
Fig. 3. bFGF/GDF-5 hydrogels stimulate Col1a1 expression and prevent the increase of 
Col3a1 expression during ligament healing. 
Col1a1 expression was increased up to 2.2- and 3.0-fold levels of control by bFGF and 
bFGF/GDF-5 hydrogels at 2 weeks after MCL injury, respectively (A). No significant 
difference in Col1a1 expression was observed among 5 groups at 4 weeks (B). Col3a1 
expression was stimulated up to a 2.8-times higher level of control by bFGF hydrogels at 2 
weeks (C). Administration of GDF-5 prevented the increase of Col3a1 expression (C, GDF-5 
and bFGF/GDF-5). No significant increase of Col3a1 was observed among each group at 4 
weeks (D). Open, dotted, diagonal-hatched, gray, and hatched gray bars indicate relative 
collagen expressions in the groups of no treatment, hydrogels alone, bFGF, GDF-5, and 
bFGF/GDF-5 hydrogels, respectively. * p < 0.05. 
 
Fig. 4. bFGF and GDF-5 cooperatively regulate collagen synthesis during the 
remodeling process of ligament injury. 
(A, anti-type I collagen antibody; B, anti-type III collagen antibody) Immunohistochemical 
analyses revealed that type I collagen synthesis was increased in bFGF-containing hydrogels 
at 2 and 4 weeks after surgery (A, bFGF and bFGF/GDF-5). The fiber alignment of type I 
collagen was well-organized in bFGF/GDF-5-hydrogel group at 4 weeks (A). The deposition 
of type III collagen was increased in bFGF-hydrogel group (B, bFGF). The synthesis of type 
 18
III collagen was maintained at a low level in GDF-5-containing group (B, GDF-5 and 
bFGF/GDF-5). Bars, 25 μm. 
(C-F) The signal density of immunohistochemical staining was evaluated. Type I collagen 
deposition was increased up to a 5.3-fold level of partial excision control by bFGF/GDF-5 
hydrogels at 4weeks (D). However, type III collagen deposition was inhibited by 
bFGF/GDF-5-combined treatment (E and F). On the other hand, bFGF hydrogels stimulated 
the deposition of both type I and III collagens in repairing tissue at 4 weeks after MCL injury 
(E and F). Open, dotted, diagonal-hatched, gray, and hatched gray bars indicate each signal 
density in the groups of no treatment, hydrogels alone, bFGF, GDF-5, and bFGF/GDF-5 
hydrogels, respectively. * p < 0.05. 
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